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Abstract
Background: The Beck Depression Inventory (BDI) is used worldwide for detecting depressive 
symptoms. This questionnaire has been revised (1996) to match the DSM-IV criteria for a major 
depressive episode. We assessed the reliability and the validity of the Brazilian Portuguese 
version of the BDI-II for non-clinical adults. Methods: The questionnaire was applied to 60 
college students on two occasions. Afterwards, 182 community-dwelling adults completed the 
BDI-II, the Self-Report Questionnaire, and the K10 Scale. Trained psychiatrists performed face-
to-face interviews with the respondents using the Structured Clinical Interview (SCID-I), the 
Montgomery-Åsberg Depression Scale, and the Hamilton Anxiety Scale. Descriptive analysis, signal 
detection analysis (Receiver Operating Characteristics), correlation analysis, and discriminant 
function analysis were performed to investigate the psychometric properties of the BDI-II. Results: 
of internal consistency was 0.93. Taking the SCID as the gold standard, the cut-off point of 10/11 
of 87%. The concurrent validity (a correlation of 0.63-0.93 with scales applied simultaneously) 
Conclusion: The BDI-II is reliable and valid for measuring depressive symptomatology among 
Portuguese-speaking Brazilian non-clinical populations. 
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Validação da versão brasileira em português do Inventário de Depressão de Beck-II 
numa amostra da comunidade
Resumo
Objetivos: O Inventário de Depressão de Beck (IDB) é utilizado mundialmente para detectar 
sintomas depressivos. Este questionário foi revisado (1996) para se adequar aos critérios do DSM-IV 
brasileiro do IDB-I em uma amostra não clínica de adultos. Métodos: O questionário foi aplicado em 
duas ocasiões para 60 estudantes universitários. Em seguida, 182 adultos residentes na comunidade 
preencheram IDB-II, Questionário de Auto-Resposta e escala K10. Psiquiatras treinados entrevistaram 
pessoalmente os respondentes através da Entrevista Clínica Estruturada (SCID-I), a escala de depressão 
de Montgomery-Åsberg e de ansiedade de Hamilton. Análise descritiva, detecção de sinal (Receiver 
Operating Characteristics), correlação e função discriminante foram realizadas para investigar as 
propriedades psicométricas do IBD-II. Resultados
o ponto de corte de 10/11 foi o melhor limiar para detectar depressão, alcançando sensibilidade de 
indivíduos deprimidos) foram aceitáveis. Conclusão
DESCRITORES:
Depressão, 
Escala de depressão, 
validade, 
Inventário de Depressão 
de Beck, Brasil.
Introduction
The Beck Depression Inventory (BDI) is a self-rating instru-
ment that is extensively used worldwide. Originally proposed 
by Beck and colleagues, the scale was revised in 1996 to 
include the DSM-IV criteria for a major depressive episode 
(MDE).1 The BDI-II2 has been translated from English into 
several other languages and features sound psychometric 
properties regarding its applicability and validity. Given 
the high prevalence of depressive disorders, the validation 
process comprises an essential step to extend its use to a 
wide range of populations. 
Aim of the study
Considering the need to validate a version of the instrument 
in a new language, the objective of this study is to examine 
the psychometric properties of the Brazilian Portuguese 
version of the BDI-II3 in terms of reliability, criteria, and 
concurrent validity. We report evidence supporting the 
validity of the BDI-II in detecting MDEs and overlaps with 
anxiety and psychological distress, considering the SCID-I as 
the gold standard. 
Methods
The English version of the BDI-II was translated into Brazilian 
Portuguese by two bilingual researchers (Y.P.W. and C.G.) 
from the University of São Paulo and back-translated by a 
native-speaker. Semantic equivalence was discussed with two 
bilingual clinical psychiatrists. Subsequently, this version was 
compared with an independent Brazilian translation that 
was developed by a clinical psychologist at another university. 
The conciliated version was submitted to an expert panel 
discussion composed of one clinical psychiatrist, two clinical 
psychologists, and one psychopharmacologist, all of whom were 
had clinical experience in depressive conditions. This version 
was submitted to a new back-translation. Before applying the 
instrument to the target samples, the BDI-II was pilot-tested 
Therefore, the current version differs slightly from the previous 
Portuguese version of the BDI-II that was proposed in Portugal.4 
Participants
Two independent samples were drawn to document different 
psychometric properties of the BDI-II: a student sample, for retest 
reliability, and a community sample to establish the best cutoff 
point for and the validity of the BDI-II with external criteria.
Sample 1
The BDI-II was administered to 60 medical students of the 
Universidade de São Paulo (mean age = 24.6 years, SD = 1.2, 
range = 22-26, with 51% women). The students completed the 
BDI-II,3 the Self-Report Questionnaire (SRQ-20),5 and the K10 
scale6 in their classroom on two occasions, with an average 
interval length of 15 days. 
Sample 2
Subsequently, a convenience sample of 182 adult participants 
drawn from a population-based household survey of the met-
ropolitan area of São Paulo7 completed the BDI-II,3 the SRQ-20,5 
and the K106 at the Institute of Psychiatry. Regardless of their 
mental health or physical condition, the participants were liv-
ing in their household at the time of the assessment. The mean 
age of this community-dwelling sample was 41 yo. (SD = 10.8, 
range = 20-60), the mean number of years of education was 9.4 
(SD = 3.9, range = 2-19), and 102 participants were female (56%). 
All participants underwent face-to-face interviews that used the 
Structured Clinical Interview (SCID-I)8 anchored with the Clinical 
Global Impression (CGI),9 the Montgomery-Åsberg Depression 
Rating Scale (MADRS),10 and the Hamilton Anxiety Scale (HAM-A).11 
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Measures
The BDI-II2,3 consists of 21 sets of statements about depres-
sive symptoms in the last 15 days that are rated on a 0-to-3 
ordinal scale, yielding total scores ranging from 0 to 63. The 
suggested thresholds1 for levels of severity were as follows: 
0-13, minimal/no depression; 14-19, mild depression; 20-28, 
moderate depression; and 29-63, severe depression. 
The following comparison instruments were applied 
consecutively to further assess the criterion-based validity 
of the BDI-II:
1) Structured Clinical Interview for DSM-IV Axis I 
Disorders (SCID-I)8 and the Clinical Global Impression 
Scale (CGI)9 
2) Montgomery-Åsberg Depression Rating Scale 
(MADRS)10 
3) Hamilton Anxiety Scale (HAM-A)11
4) Kessler's psychological distress scale (K10)5
5) Self-Report Questionnaire (SRQ-20)6 
This study was approved by the Ethics Committee of the 
University Hospital Board and written informed consent was 
obtained from the participants before they entered the study.
Data analysis strategy
Descriptive analyses, the intraclass correlation (ICC) of the 
(Cronbach's alpha) of the BDI-II of the community sample 
were computed. Subsequently, signal detection analyses 
against the diagnoses of the SCID-I/MDE were conducted for 
all possible BDI-II scores by building the Receiver Operating 
Characteristics (ROC) curve. Positive predictive value (PPV), 
negative predictive value (NPV), and the percentage of 
misclassification were calculated. After classification 
of subjects into depressed and non-depressed subgroups 
according to the best threshold, Spearman's correlations of 
Pearson's correlations between the BDI-II and the psy-
chometric tools were calculated. The discriminant function 
analysis was executed according to the severity level of the 
BDI-II using a canonical discriminant function to predict 
the category membership of the severity level and using the 
diagnosis of SCID-I/MDE as the criterion. All analyses were 
for two-tailed tests. 
Results
for the student sample was 0.89 (95%CI 0.82-0.93). The 
sample was 0.93, and the alphas were 0.92 and 0.93 for male 
and female subgroups, respectively. The item-total correla-
tion ranged from 0.44 to 0.73, indicating satisfactory item 
homogeneity for assessing the underlying construct.
The mean score and the standard deviation (SD) of each 
BDI-II item are displayed in Table 1 for the total sample and 
women (7.88 vs. 11.43; F = 5.05; p < 0.05).
Table 1 Means, standard deviations, and corrected item-total correlations of the BDI-II for the total sample and for the 
subgroups of men and women
Total  
(n = 182)
Men 
(n = 80)
Women 
(n = 102)
Item Mean SD r Mean SD r Mean SD r
01 Sadness 0.35 0.65 0.66 0,20 0.20 0.56 0.47 0.71 0.69
02 Pessimism 0.35 0.66 0.60 0,30 0.30 0.48 0.38 0.65 0.68
03 Past Failure 0.36 0.77 0.59 0,30 0.30 0.58 0.41 0.82 0.59
04 Loss of Pleasure 0.51 0.82 0.71 0,40 0.40 0.61 0.60 0.90 0.76
05 Guilty Feelings 0.44 0.70 0.55 0,39 0.39 0.50 0.48 0.73 0.57
06 Punishment Feelings 0.32 0.83 0.44 0,35 0.35 0.63 0.30 0.79 0.35
07 Self-Dislike 0.28 0.69 0.67 0,21 0.21 0.64 0.33 0.75 0.68
08 Self-Criticalness 0.47 0.80 0.52 0,39 0.39 0.46 0.53 0.90 0.54
09 Suicidal Thoughts 0.10 0.37 0.53 0,10 0.10 0.71 0.11 0.31 0.44
10 Crying 0.64 1.03 0.47 0,59 0.59 0.46 0.69 0.98 0.49
11 Agitation 0.48 0.87 0.50 0,43 0.43 0.43 0.53 0.89 0.55
12 Loss of interest 0.39 0.76 0.72 0,25 0.25 0.69 0.50 0.86 0.72
13 Indecisiveness 0.64 0.94 0.69 0,50 0.50 0.74 0.75 1.02 0.66
14 Worthlessness 0.27 0.63 0.73 0,13 0.13 0.74 0.39 0.73 0.73
15 Loss of Energy 0.70 0.76 0.69 0,64 0.64 0.60 0.75 0.85 0.73
16 Changes in Sleeping 0.76 0.90 0.61 0,64 0.64 0.56 0.86 0.94 0.62
17 Irritability 0.46 0.79 0.69 0,35 0.35 0.75 0.55 0.87 0.66
18 Changes in Appetite 0.58 0.87 0.61 0,48 0.48 0.58 0.66 0.96 0.61
19 0.58 0.79 0.63 0,54 0.54 0.64 0.61 0.83 0.62
20 Tiredness 0.62 0.82 0.67 0,46 0.46 0.68 0.75 0.91 0.66
21 Loss of Interest in Sex 0.53 0.89 0.51 0,28 0.28 0.29 0.73 1.05 0.57
Total 9.87 10.71 0.93† 7.88 9.12 0.92† 11.43* 11.62 0.93†
SD: Standard-Deviation; r: item-total correlation.
†
*One-way ANOVA F = 5.05, p < 0.05.
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Table 2 
Inventory-II for the diagnosis of a Major Depressive Episode, according to the cutoff points of the total score of the scale 
against the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I)
Cut-off Sensitivity PPV NPV
% % % % %
0/1 95.0 23.0 100.0 33.0 67.0
1/2 91.7 32.8 91.1 53.3 46.7
2/3 90.0 40.2 90.9 55.5 44.5
3/4 90.0 44.3 90.0 57.1 42.9
4/5 86.7 52.5 88.9 61.5 38.5
5/6 86.7 59.8 90.1 66.5 33.5
6/7 81.7 65.6 87.9 68.7 31.3
7/8 80.0 70.5 87.8 72.0 28.0
8/9 73.3 77.0 84.5 73.1 26.9
9/10 70.0 78.7 83.3 73.1 26.9
10/11 70.0 84.4 84.3 77.0 23.1
11/12 63.3 86.9 82.0 76.4 23.6
12/13 61.7 87.7 81.5 76.4 23.6
13/14 58.3 87.7 80.3 75.3 24.7
14/15 56.7 88.5 79.9 75.3 24.7
15/16 51.7 90.2 77.7 73.6 26.4
16/17 50.0 91.0 77.3 73.6 26.4
17/18 48.3 91.8 77.6 74.7 25.3
18/19 45.0 93.4 76.2 74.2 25.8
19/20 43.3 95.1 76.0 75.3 24.7
20/21 40.0 98.4 75.6 76.4 23.6
21/22 35.0 98.4 74.2 75.3 24.7
22/23 30.0 98.4 73.5 74.7 25.3
23/24 28.3 98.4 73.0 74.2 25.8
24/25 23.3 98.4 72.3 73.6 26.4
25/26 21.7 98.4 71.9 73.1 26.9
27/28 20.0 98.4 71.4 72.5 27.5
29/30 20.0 99.2 71.6 73.1 26.9
30/31 18.3 99.2 71.8 73.6 26.4
31/32 15.0 100.0 70.5 72.0 28.0
32./33 13.3 100.0 70.1 71.4 28.6
34/35 11.7 100.0 69.7 70.8 29.1
38/39 10.0 100.0 69.3 70.3 29.7
41/42 8.3 100.0 68.9 69.8 30.2
43/44 5.0 100.0 68.2 68.7 31.3
47/48 3.3 100.0 67.8 68.1 31.9
50/51 1.7 100.0 67.4 67.6 32.4
52/53 0.0 100.0 67.0 67.0 33.0
PPV: Positive predictive value; NPV: Negative predictive value
All possible scores of the BDI-II were compared with the 
cases of the SCID-I/MDE (Table 2). The best cut-off point 
was 10/11. This threshold showed a sensitivity of 70% and 
 
The area under the ROC curve indicated that the instrument 
could discriminate 82.1% (95%CI 75-89) of cases of MDE, 
demonstrating substantial accuracy. 
When adopting a cut-off of 10/11, 121 subjects were 
 
as depressed (BDI > 10). The proportions of CGI scores were as 
as "not ill/minimally ill" (CGI 1-3), and 64.6% of depressed 
subjects exceeded the "moderately ill" level (CGI 4-7). The 
CGI was correlated with the BDI-II score and the dichotomous 
Adopting the diagnosis of MDE as the criterion and the 
suggested severity threshold, the best discriminative perfor-
mance of the BDI-II was observed between those individuals 
with "minimal/no depression" (scores 0-13) and those with 
"very severe" depression (scores 29-63), which were 81.1% 
and 85.7%, respectively. The overall predictive ability of 
Regarding concurrent validity, the correlations between 
the BDI-II and the SRQ-20 were 0.67 and 0.89 for the stu-
dent and community samples, respectively. Likewise, the 
M.H. Gomes-Oliveira et al.
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correlations with the K10 were 0.63 and 0.93. The correlation 
with the MADRS was 0.75, and that for the HAM-A was 0.66 
in the community sample. 
Discussion
-
formance of the Brazilian Portuguese version of the BDI-II in 
a non-clinical population. The instrument showed temporal 
stability and was internally consistent and valid for predict-
ing the presence of depressive symptoms. While most studies 
have assessed student samples, our main data, along with 
the clinical interviews, come from community adults across 
of the self-rated score of depression was also correlated with 
a clinical assessment of severity. 
The reliability of the Brazilian Portuguese version is 
version.2 In general, the internal consistencies of linguisti-
cally diverse versions of the BDI-II have been described as 
robust underlying construct and displays the representative 
value for the Brazilian data of approximately 0.90 supports 
reported for the versions in English and Spanish,12 Turkish,13 
and Icelandic.14 
As in most of the published investigations on the BDI-II, 
an effect of gender emerged consistently in the total score. 
The gender bias of the BDI-II is invariantly found in instru-
ments used to assess depression, and this bias deserves 
future investigation. 
There is controversy in the literature about the cut-score 
ranges used to categorize mildly, moderately, and severely 
depressed individuals.1
(10/11 for dysphoria and 15/16 mild depression), Dozois et al.15 
the higher cut-offs of 13/14 and 20/21 improved the sen-
et al.16 showed that the threshold of 18/19 is an adequate 
severe depression. 
Our cut-off point of 10/11 is similar to the thresholds of 
Canadian15 and Turkish studies.13 In contrast, the sensitivity 
-
ity (87.7%) when the threshold to detect mild depression 
is increased to 13/14.2 Moreover, with a higher threshold 
are observed. If the suggested cut-off of 26/27 for severe 
depression is adopted,2 the sensitivity becomes too trivial 
for detecting depression (21.7%). The 10/11 threshold of this 
Brazilian Portuguese version works well in binary prediction 
for 82% of depression vs. non-depression cases. While the 
predictive capacity for different levels of severity is accept-
able, it is lower than the 87% value of the Icelandic study.14 
The BDI-II demonstrated high correlations with instru-
ments applied simultaneously. In the literature, the overlap 
of the construct assessed by the BDI-II and common scales 
used to screen for depression (e.g., MADRS, HAM-D) ranged 
between 0.69 and 0.86. In our investigation, the BDI-II also 
showed good correlations with scales of general psychopa-
thology, such as the K10 and SRQ-20. 
Some weaknesses of this study should be noted. The 
sample was assessed in a health care setting, which may 
bias the results. Participants may have exaggerated their 
symptoms to obtain treatment for health problems. However, 
our results are comparable most international studies and 
ensure the applicability of the BDI-II to non-clinical samples. 
Additionally, the adoption of the SCID-I as the criterion may 
frame exceeds that of the BDI-II, which only assesses the 
past two weeks. Therefore, some depressive symptoms may 
have remitted to the point of being undetectable by the 
questionnaire. Likewise, the periods covered by concurrent 
instruments (e.g., SRQ-20 and K10) also outnumber the time 
length covered by the BDI-II. 
Much of the construct validity of the BDI-II remains to 
chronicity, remission, and symptomatic pattern of atypical 
presentation) should be investigated with a prospective 
design and a more inclusive sample. The applicability of 
the BDI-II should be tested in clinical samples of active 
cases of depression, epidemiological surveys, primary 
care, and general hospital settings. In conclusion, the 
indicators of reliability and validity of the Brazilian 
Portuguese version of the BDI-II were satisfactory and sup-
port its use in Brazilian non-clinical populations to predict 
probable depression.
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